These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8864202)

  • 1. Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody.
    Iacono-Connors LC; Smith JF; Ksiazek TG; Kelley CL; Schmaljohn CS
    Virus Res; 1996 Aug; 43(2):125-36. PubMed ID: 8864202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation and properties of monoclonal antibodies to tick-borne encephalitis viral nonstructural proteins].
    Matveeva VA; Dobrikova EIu; Tsekhanovskaia NA; Popova RV; Pressman EK; Karavanov AS; Matveev LE
    Vopr Virusol; 1998; 43(3):134-7. PubMed ID: 9702814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of monoclonal antibodies against Hokkaido strain tick-borne encephalitis virus.
    Komoro K; Hayasaka D; Mizutani T; Kariwa H; Takashima I
    Microbiol Immunol; 2000; 44(6):533-6. PubMed ID: 10941938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
    Tsouchnikas G; Zlatkovic J; Jarmer J; Strauß J; Vratskikh O; Kundi M; Stiasny K; Heinz FX
    J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
    Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibody study of antigens E and NS1 of Western Siberian tick borne encephalitis virus strains].
    Bakhvalova VN; Karavanov AS; Matveev LE; Matveeva VA; Morozova OV
    Vopr Virusol; 2001; 46(6):33-6. PubMed ID: 11785385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic structure of the Murray Valley encephalitis virus E glycoprotein.
    Hawkes RA; Roehrig JT; Hunt AR; Moore GA
    J Gen Virol; 1988 May; 69 ( Pt 5)():1105-9. PubMed ID: 2453607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic analysis of flaviviruses with monoclonal antibodies against Negishi virus.
    Furuta I; Takashima I; Arikawa J; Hashimoto N
    Microbiol Immunol; 1984; 28(9):1023-30. PubMed ID: 6096680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic analysis of tick-borne encephalitis virus group using monoclonal antibodies and immunofluorescence].
    Gaĭdamovich SIa; Sveshnikova NA; Stephenson JR; Lee JM; Mel'nikova EE
    Vopr Virusol; 1989; 34(6):684-9. PubMed ID: 2699124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a protective epitope in Japanese encephalitis virus NS1 protein.
    Zhou D; Pei C; Liu Z; Yang K; Li Q; Chen H; Cao S; Song Y
    Antiviral Res; 2020 Oct; 182():104930. PubMed ID: 32898585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus].
    Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA
    Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic analysis of tick-borne encephalitis complex viruses by time-resolved fluoroimmunoassay with monoclonal antibodies.
    Pomelova VG; Gaidamovich SY; Stephenson JR; Lavrova NA; Sveshnikova NA
    J Virol Methods; 1991; 31(2-3):293-300. PubMed ID: 1713917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein].
    Timofeev AV; Kondrat'eva IuIu; Karganova GG; Stephenson J
    Vopr Virusol; 2001; 46(1):22-4. PubMed ID: 11233282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.
    Falconar AK
    Clin Vaccine Immunol; 2008 Mar; 15(3):549-61. PubMed ID: 18160621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change in the antigenic structure of surface glycoprotein E of tick-borne encephalitis virus during its adaptation to ticks and mammals].
    Romanova LIu; Gmyl' LV; Loktev VB; Protopopova EV; Dzhivanian TI; Lashkevich VA; Karganova GG
    Vopr Virusol; 2006; 51(6):31-4. PubMed ID: 17214080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus.
    Hall RA; Kay BH; Burgess GW; Clancy P; Fanning ID
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2923-30. PubMed ID: 1703213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
    Kreil TR; Maier E; Fraiss S; Eibl MM
    J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.